Trials / Completed
CompletedNCT03148574
Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery
Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery to Reduce Intraoperative and Postoperative Blood Loss: A Randomized Clinical Trial.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Bleeding is still the major cause of mortality and morbidity in postpartum period. World health organization has reported 585000 deaths for pregnancy each year. Twenty five percent of cases die from post-partum bleeding. Mean amount of blood lost is 500 ml during normal vaginal delivery, 1000 ml in cesarean section, and 3500 ml during cesarean section with emergency hysterectomy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol | intrauterine tablets |
| DRUG | Oxytocin | intravenous |
Timeline
- Start date
- 2017-07-02
- Primary completion
- 2019-09-15
- Completion
- 2019-12-15
- First posted
- 2017-05-11
- Last updated
- 2021-04-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03148574. Inclusion in this directory is not an endorsement.